We serve Chemical Name:3-Fluoro-5-Bromoaniline CAS:134168-97-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Fluoro-5-Bromoaniline
CAS.NO:134168-97-1
Synonyms:ZR CF EE;Benzenamine, 3-bromo-5-fluoro-;3-Bromo-5-fluoroaniline;3-Fluoro-5-bromoaniline;3-Bromo-5-fluorobenzenamine
Molecular Formula:C6H5BrFN
Molecular Weight:190.013
HS Code:2921420090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:245.5±20.0 °C at 760 mmHg
Density:1.7±0.1 g/cm3
Index of Refraction:1.597
PSA:26.02000
Exact Mass:188.958939
LogP:2.54
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like ZR CF EE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Bromo-5-fluorobenzenamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Fluoro-5-bromoaniline Use and application,3-Bromo-5-fluoroaniline technical grade,usp/ep/jp grade.
Related News: The continuous acceleration of the industrial transfer process has provided a huge market space for the fine chemical intermediate industry. 3-Fluoro-5-Bromoaniline manufacturer Separately, Europe’s drug regulator said on Friday that batches of J&J COVID-19 vaccine made for the region around the time the contamination issues were revealed at the Baltimore plant would, as a precaution, not be used. 3-Fluoro-5-Bromoaniline supplier Lilly has denied retaliating against any employees, and no lawsuit has been filed on behalf of Mula. 3-Fluoro-5-Bromoaniline vendor Lilly has denied retaliating against any employees, and no lawsuit has been filed on behalf of Mula. 3-Fluoro-5-Bromoaniline factory After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply.
